[Advance in clinical research on Antley-Bixler syndrome]

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2018 Apr 10;35(2):280-283. doi: 10.3760/cma.j.issn.1003-9406.2018.02.031.
[Article in Chinese]

Abstract

Antley-Bixler syndrome (ABS) is a rare childhood disorder affecting skeletal development. Some patients may also have genital anomalies and impaired steroidogenesis. Diagnostic criteria for ABS has not been fully established, though craniosynostosis, midface hypoplasia and elbow synostosis are minimum requirements. The etiology of ABS is complex, which included autosomal dominant form caused by FGFR2 gene mutations, autosomal recessive form caused by POR gene mutations, and high oral dose of fluconazole during pregnancy. Patients may die from dyspnea due to upper respiratory tract obstruction. This review summarizes research progress on the clinical features, etiology, differential diagnosis, treatment and prevention of ABS.

Publication types

  • Review

MeSH terms

  • Animals
  • Antley-Bixler Syndrome Phenotype / diagnosis
  • Antley-Bixler Syndrome Phenotype / etiology
  • Antley-Bixler Syndrome Phenotype / genetics*
  • Antley-Bixler Syndrome Phenotype / therapy
  • Cytochrome P-450 Enzyme System / genetics
  • Diagnosis, Differential
  • Fetus / drug effects
  • Fluconazole / adverse effects
  • Humans
  • Receptor, Fibroblast Growth Factor, Type 2 / genetics

Substances

  • POR protein, human
  • Fluconazole
  • Cytochrome P-450 Enzyme System
  • FGFR2 protein, human
  • Receptor, Fibroblast Growth Factor, Type 2